Research Axes
Health Economics
Description
This axis focuses on institutionalizing the use of evidence in health care decision-making, and promoting health equity through health technology assessment, review of health economics guidelines, assessment of the economic and clinical burden of acute and chronic diseases with special focus on infections and antimicrobial resistance. It aims at bridging the gap between research and implementation by developing national guidelines for the conduct and dissemination of health economics studies (cost of illness and health-economic evaluation), and generating standardized resource-use measures and country-specific utility weights, in addition to a societal willingness-to-pay threshold.
Recommendations
01
Creating a national multidisciplinary Health technology assessment division in the MOPH.
02
Writing national policy and procedures for health technology assessment.
03
Setting a mandatory national surveillance and reporting system for all communicable and non-communicable diseases.
04
Writing the methodology for data access, evaluation and validation.
05
Integrating health technology assessment in drug registration process and in reimbursement strategies.
06
Creating disease related groups.
07
Reviewing of health economics guidelines.